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Introduction and Aim. Injecting drug users (IDUs) are amongst the most vulnerable people to acquisition of HIV/AIDS.This study
aims to collect information on IDUs and their health seeking behavior in Bangladesh. Design and Methods. A cross-sectional
study was conducted among 120 IDUs attending a drug rehabilitation center in Dhaka, Bangladesh. Data were collected on
sociodemographics, drug use, health seeking behavior, knowledge of injecting drugs, and sexual behavior. Results. The mean ±
SD and median (IQR) age of the participants were 32.5 ± 21.3 and 33 (27–38) years, respectively, with only 9.2% females. Injection
buprenorphine was the drug of choice for 40% of participants, and 58% of the participants first started drug use with smoking
cannabis. 73.3% of participants shared needles sometimes and 57.5% were willing to use the needle exchange programs. 60% of
the participants had no knowledge about the diseases spread by injection. Condom use during the last intercourse with regular
partners was 11.7% and with any partners 15.8%. Conclusion. IDUs in Bangladesh are a high-risk group for HIV/AIDS due to lack of
knowledge and risky behaviors. Education and interventions specifically aimed at IDUs are needed, because traditional education
may not reach IDUs or influence their behavior.
1. Introduction
Drug abuse is an alarming and complex problem in
Bangladesh where there are an estimated 1.7 million drug
abusers and the number has been increasing greatly over
recent years [1]. According to a research in Bangladesh, the
amount of money drug abusers spent per year is US$707–
1,135 per person which was much higher than the per-capita
income of Bangladeshi people (US$380 in 2001) [1]. The
study projected that the total amount spent by 1.7 million
drug abusers in Bangladesh would be US$1.2–1.9 billion.
Moreover, the actual cost of drug abuse would be far more if
we include other related social and economic impacts. Drug
users and injecting drug users (IDUs) are people who use
or inject illegal drugs despite negative consequences to one’s
health. Drug use has played a major role in the spread of
HIV/AIDS inmany countries.Thehigh level ofHIV infection
among IDUs is a major health problem of international
concern [2]. Drug users also function as a “bridge” for HIV
transmission to the heterosexual population and to children
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through perinatal transmission [3]. Bangladesh is predom-
inantly a Muslim country with over 150 million people,
located between India and Myanmar, and a low prevalence
country for HIV/AIDS. The estimated number of IDUs in
Bangladesh was 20000–40000 in 2008 and the numbers are
increasing rapidly [4, 5].The capital cityDhaka hasmore than
12 million people. A previous study in Bangladesh reported
HIV epidemic concentrated among IDUs in Dhaka city
[6].
In the past few years, some 10–20 percent of the drug users
have become new injectors. In the southeast of the country,
60% of all IDUs have only started injecting within the last
two years [7]. The prevalence of HIV in Bangladesh is less
than 0.1% in the general population and has remained less
than 1% over the years including most at risk population
such as clients of sex workers and IDUs [8]. However, studies
showed that although Bangladesh is a low prevalence country
for HIV/AIDS, all the factors that may allow rapid spread
of an AIDS epidemic are present in this country. These
include high-risk behavior, lack of awareness, very mobile
populations, and being surrounded by countries that have a
higher prevalence of HIV. According to the latest Serological
Surveillance (Round 9, 2011) of Bangladesh, the HIV preva-
lence among drug users, male and female sex workers, men
who have sexwithmen (MSM), and transgender or hijras was
0.7% [4].
The Round 9 Surveillance tested 7,529 drug users (IDUs,
heroin smokers, and the combined group of IDUs and heroin
smokers) from 30 different cities in Bangladesh. Overall HIV
prevalence was 1.2%, with low rates found in drug users from
five cities. In Dhaka the prevalence of HIV among IDUs
was 5.3%. Though active syphilis rates among IDUs declined
significantly over time in Dhaka, there were no significant
changes in the other cities where trend analysis was possible.
Hepatitis C virus (HCV) was present in over 50% of IDUs
in six of the cities. However, the highest prevalence of HCV
was found among IDUs in several cities, with 95.7% as the
highest in a northwestern city [4, 9]. Another study among
IDUs in Bangladesh reported the prevalence of HIV 5.6%
[10]. However, treatment for drug dependence and needle
exchange programs (NEPs) are virtually the only services
available to IDUs in Bangladesh, mostly through NGOs and
with little support from the government. Opioid substitution
therapy and access to antiretroviral treatment for IDUs were
generally not available in the country [11].
There is growing recognition that healthcare seeking
behaviors and local knowledge need to be considered in
programs and interventions to promote health in a variety
of contexts [7]. Previous studies in Bangladesh have reported
the prevalence and different programs directed towards
the IDUs. Information regarding personal profile of IDUs
and their health seeking behavior is needed to develop
prevention strategies and policy recommendation to combat
HIV/AIDS in this risky group of population. However, there
is limited data on IDUs and their health seeking behavior in
Bangladesh. We, therefore, conducted this study to identify
the personal profile of injecting drug users (IDUs) in Dhaka
city and their health seeking behavior.
2. Materials and Methods
2.1. Study Design, Place, and Population. We conducted a
cross-sectional study between March and September 2005
among 120 IDUs attending the Society for Community-
Health Rehabilitation Education and Awareness (CREA),
a drug addiction treatment and rehabilitation center at
Mohammadpur, Dhaka. Participants were selected purposely
from newly admitted cases attending a counseling session
at the center and referred by attending physician/counselor.
The inclusion criteria were as follows: participants who used
injection of one or more drugs (excluding insulin or other
prescribed medications for any illness) within the last 3
months prior to the interview, admission within the last 30
days, no history of severe mental disorders, and ability to
provide written informed consent.
2.2. Data Collection Tools. Data were collected through face-
to-face interviews using a structured questionnaire in Ben-
gali. The questionnaire was developed by a team of epidemi-
ologists, physicians, psychologists, and social scientists and
pretested among 20 IDUs attending the outpatient depart-
ment at a drug addiction treatment center in Tejgaon, Dhaka.
During the pretest phase we considered if the questions were
too sensitive to answer, level of difficulty, and privacy of the
respondents. After pretest, the questionnaire was modified
and used for data collection in this study.
2.3. Ethics. Before data collection, permission was obtained
from the head of the drug addiction treatment center and
attending physicians and counselors. All participants in the
study were informed of the objectives of the study and that
they were free to participate by their own will and that their
opinion or withdrawal will have no consequences on their
treatments. Written informed consent was obtained from all
the participants prior to the interview.The study protocol was
approved by the Institutional Review Board of the National
Institute of Preventive and Social Medicine (NIPSOM).
2.4. Variables, Data Entry, and Analysis. Information on
age, sex, religion, living alone or with family, marital status,
number of dependencies in the family, education, occupa-
tion, source of income, and monthly average income by
the respondent (self-income) and types of drug used and
duration was collected. Health seeking behavior in terms
of primary point of care, reason for delay or not taking
treatment earlier, information about needle sharing, rea-
sons for needle sharing, and information regarding needle
exchange program (NEP) were collected. Sharing means
using someone else’s equipment, which has already beenused,
or someone using the respondents’ equipment, regardless
of whether both the participant and the user were present
at the time. Injecting equipment included needles, syringes,
filters, spoons and cookers, and washouts. Sharing of needles
and equipment was classified as “always” = shared during
every use, “sometimes” = shared anytime, and “never” =
never shared. NEP refers to organized needle exchange
programs available to IDUs throughNGOs and at no cost.We
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also collected information on level of knowledge about the
consequences of the diseases transmitted by injecting drugs
and about the sexual behavior of the respondents such as
sex with regular partners, sex during the last three months,
condom use during the last sexual intercourse, and condom
use with any partners. Regular partner refers to having sexual
intercourse with a single partner on a regular basis, such as a
wife or a fixed girlfriend.
All data were prospectively recorded on case report
forms. Data that were missing, inconsistent, or both were
obtained or clarified by direct communication of the data
collectors. Data entry and analysis was performed using
Microsoft Excel. Data were presented as frequency (𝑛) and
percentage (%).Mean and standard deviationwere calculated
for normal distribution and median and interquartile range
(IQR) were reported for nonnormal distribution data.
3. Results
Table 1 shows the sociodemographic characteristics of study
participants. 120 IDUs participated in this study with a mean
± SD age of 32.5 ± 21.3 years. The age range was from 13
to 62 years. Almost half (48%) of the participants were in
the age group 30–39 years, followed by 21.7% aged 40 years
or more, and the rest were in other age groups. 91% of the
study participants were male. A great majority of the IDUs
were Muslims (76.7%), living alone (57.5%), and unmarried
(45.0%) and had no dependent person to take care of (40.8%).
More than two-thirds of the respondents had no education or
only completed primary level of education. About half of the
participants (55%) were unemployed and 49.2% mentioned
self-income as the only sources of income. The mean ±
SD monthly income of the participants was 10450 ± 7300
Bangladeshi Takas (BDT) (1 US$ = 78.9 BDT).
Drug use of the participants is presented in Table 2.
The main drug used or the drug of choice was injection
buprenorphine (40.0), followed by other injections or mixed
form of injections (25.8%), injection pethidine (18.3%), and
injection sedatives (15.8%). Almost half of the participants
(50.8%) mentioned smoking cannabis (ganja or marijuana)
as the first drug used and 18.3% started with a cough-syrup
(Phensedyl). A great majority of the participants (51.7%)
started taking first drug during the age of 16–24 years and
less than 10% initiated drug use after 44 years. However, a
greater number of participants (30.8%) mentioned injecting
first drug during the age of 25–34 years.The average duration
of taking injectable drug was 15.4 ± 2.3months.
Table 3 presents the health seeking behavior of the
respondents. About one-third (33.3%) of the participants
reported local MBBS (Bachelor of Medicine and Bachelor of
Surgery) doctors or registered physicians as primary point
of care, followed by private medical centre (19.2%), govern-
ment health centre (10.8%), local pharmacy (10.0%), and
paramedics, Ayurvedic, homeopathics, quacks, or traditional
healers (8.3%). About 18.3% of the participants reported not
seeking healthcare before. During the interview, the majority
of the respondents (40.0%) mentioned that for drug addic-
tion problem they did not know where to go for treatment,
Table 1: Sociodemographic information of the respondents (𝑛 =
120).
Variables Number(𝑛)
Percentage
(%)
Age group in years
10–19 13 10.8
20–29 23 19.2
30–39 58 48.3
40 or more 26 21.7
Sex
Male 109 90.8
Female 11 9.2
Religion
Muslim 92 76.7
Hindu 17 14.2
Christians and others 11 9.2
Living status
Alone 69 57.5
With family 51 42.5
Marital status
Married 47 39.2
Unmarried 54 45.0
Divorcee/separated 19 15.8
Number of dependent persons
None 49 40.8
1-2 32 26.6
3-4 25 20.8
More than 4 14 11.6
Education
None 39 32.5
Primary (up to grade 5) 46 38.3
Secondary (up to grade 12) 23 19.2
Graduate/masters (bachelor’s
degree and above) 12 10.0
Occupation
Unemployed 66 55.0
Student 12 10.0
Govt. service 5 4.2
Business 28 23.3
Others 9 8.0
Source of income
Self 59 49.2
Parents or spouse 40 33.3
Others/no income 21 17.5
Average monthly self-income (in Taka)
Mean ± SD (10450 ± 7330)
<5000 26 21.7
5000–10000 42 35.0
10001–15000 30 25.0
15001 and above 22 18.3
30% thought that treatment was too expensive, 17.5% thought
that treatment was not effective, and only 15% mentioned
other causes. Needles and syringes sharing was a common
practice for 40% of participants, while 33.3% of participants
reported sharing needles/syringes sometimes. Among all
4 Journal of Addiction
Table 2: Distribution of respondents by drug use (𝑛 = 120).
Variables Number (𝑛) Percentage (%)
Current drug of choice
Injection pethidine 22 18.3
Injection buprenorphine 48 40.0
Injection sedatives 19 15.8
Injection (others)/mixed injections 31 25.8
Names of first drug use
Injection pethidine 10 8.3
Injection buprenorphine 6 5.0
Injection sedatives 8 6.7
Injection (others) 9 7.5
Phensedyl 22 18.3
Ganja 61 50.8
Heroin 3 2.5
Others (noninjecting) 1 0.8
Age of taking first drug (years)
<16 19 15.8
16–24 62 51.7
25–34 18 15
35–44 10 8.3
45–54 7 5.8
>55 4 3.3
Age of first injecting drug (years)
<16 7 5.8
16–24 17 14.2
25–34 37 30.8
35–44 26 21.7
45–54 10 8.3
>55 3 2.5
Duration of injecting drug use
<6 months 30 25.0
6 months–<1 year 21 17.5
1–3 years 22 18.3
3–5 years 27 22.5
More than 5 years 20 16.7
the respondents, only 4% of participants reported practicing
needle sharing always. Participants reported needle sharing
because it was cheap (10%), was convenient (18.3%), and
was considered as a norm (15%). More than half of the
participants (57.5%) were willing to use the needle exchange
programs (NEPs), while 30% mentioned not being willing
to use NEPs. Costs or loss of income (12.5%), fear of police
(5.8%), and social problems (7.5%) were reasons for not being
willing to use the NEPs.
Respondents’ knowledge about the diseases spread by
injecting drug use is presented in Table 4.Themajority of the
respondents (60.0%) had no knowledge about the diseases
spread through injections and needle sharing. Only 17.5%
of participants could mention HIV/AIDS, 6.7% syphilis,
5.8% hepatitis B or C, and 2.5% other blood-borne diseases
and 67.5% could not mention anything. Regarding knowl-
edge about protection, 29.2% of participants mentioned
Table 3: Distribution of respondents by health seeking behavior
(𝑛 = 120).
Variables Number (𝑛) Percentage (%)
Primary point of care
Govt. center 13 10.8
Private center 23 19.2
Local MBBS doctor 40 33.3
Local pharmacy 12 10.0
Paramedics/quacks/traditional 10 8.3
None 22 18.3
Reason for delay or not taking treatment earlier
Don’t know where to go 48 40.0
Treatment too expensive 36 30.0
Treatment not effective 21 17.5
Other causes 15 12.5
Needle sharing
Always 48 40.0
Never 32 26.7
Sometimes 40 33.3
Reason for needle sharing (𝑛 = 88)
Cheap 12 10
Convenient 22 18.3
No problem known 24 20
Norm 18 15
Don’t know 12 10
Willing to use NEP
Yes 69 57.5
No 36 30.0
Don’t know 15 12.5
Reason for not being willing to use NEP (𝑛 = 36)
Costs or loss of income 15 12.5
Fear of police 7 5.8
Social problems 9 7.5
Don’t know 5 4.2
not injecting any more drugs, 34.2% mentioned cleaning
syringe/needle, 10% mentioned using condoms, and 5%
reported that taking medicine can protect them from harms.
When asked about the consequences of drug use, themajority
of the participants mentioned the adverse effects of injecting
drug use on their health, occupation, and family (Table 4).
Table 5 presents the sexual behavior of the participants.
A great majority of the participants had sex with regular
partners. However, only 11.7% of participants mentioned
condom use during the last sexual intercourse. When asked
about condom use with any sex partners, only 15.8% of the
participants reported using condoms.
4. Discussion
Results of our study showed that IDUs in Bangladesh are
most vulnerable to acquisition and spread of HIV/AIDS
among general population due to lack of awareness and
knowledge about HIV/AIDS and practicing risky behaviors
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Table 4: Distribution of respondents by knowledge about diseases
spread by drug use (𝑛 = 120).
Variables Number (𝑛) Percentage (%)
Knowledge about diseases spread
Yes 48 24.2
No 72 60.0
Diseases spread
HIV/AIDS 21 17.5
Syphilis 8 6.7
Hepatitis B/C 7 5.8
Other blood-borne diseases 3 2.5
Don’t know 81 67.5
Ever heard of (multiple answers possible)
HIV/AIDS 68 56.7
Syphilis 21 17.5
Hepatitis B/C 45 37.5
Knowledge about protection
Not injecting any more drugs 35 29.2
Cleaning syringe/needle with water 41 34.2
Using condoms 12 10.0
Taking medicines 6 5.0
No need 3 2.5
Don’t know 23 19.2
Consequences of drug use (multiple answers possible)
Affecting my health 103 85.8
Affecting my job/education 87 72.5
Affecting family relationships 96 80.0
Affecting socially 65 54.2
Others 51 42.5
such as high level of needle/syringe sharing and unprotected
sex. The majority of the IDUs in this study were young and
middle-aged men. This may be due to the fact that females
prefer taking injections and treatment at home instead of
drug rehabilitation centers due to social stigma [6, 12]. The
recent increase in shift to injection might result from easy
availability of injecting drugs, relatively cheaper price com-
pared to other drugs, and better surveillance and reporting
[12, 13]. A previous study in Bangladesh reported 78%of IDUs
continued stably exchanging needles and syringes, but the
reported rate of condomuse in commercial sex remained low,
improving from only 7.8% to 17.7% [14, 15]. Other studies in
Bangladesh among IDUs also reported risky sexual behaviors
among IDUs compared to non-IDUs [16, 17].
Another study among 505 “drug addicts” in Dhaka
showed those who were HIV positive (3.7%) were mainly
IDUs, and all of them shared needles. The majority of
the participants (73.3%) of our study also reported sharing
needles. Those drug users with HIV were also more likely to
report unprotected sex (76.4%), having multiple sex partners
(87.1%), and the presence of STIs (64.2%) [14]. These reports
are consistent with our findings.
The results of our study showed low awareness about the
consequences of drug use and about HIV, which is consistent
Table 5: Sexual behavior of the respondents.
Variables Number (𝑛) Percentage (%)
Sex with a regular partner
Yes 76 63.3
No 19 15.8
No response 25 20.8
Sex in the last 3 months
Yes 87 72.5
No 20 16.7
Not applicable 13 10.8
Used condom in the last sexual intercourse
Yes 14 11.7
No 84 70.0
No response 22 18.3
Used condom with any partners
Sometimes 19 15.8
Never 72 60.0
No response 29 24.2
with previous studies [18–20]. In general, most IDUs have
heard of HIV/AIDS but they are unaware of how it spreads
by injecting drugs. A marker for prevalent injection drug use
is the prevalence of hepatitis C [16]. In Dhaka the prevalence
of hepatitis C declined significantly over the years, which
showed that safer injection practices are being adopted [4].
Early intervention efforts in Bangladesh, including extensive
NEPs, are estimated to have reduced infections among IDUs
and also contributed to decrease of the transmission to other
populations [21].However, these studies have been conducted
among selected population groups and intervention subjects
and do not represent the general IDUs in the country.
It is reported that the HIV epidemics of several other
countries in Asia started off in IDUs and then spread via
needle sharing and unprotected sex with the sex workers and
thereafter to the general population [22]. In China, nearly
half of all people infected with HIV are believed to have
become infected through injecting drug use. There is often
an overlap between communities of IDUs and communities
of sexworkers inmany parts ofAsia, as thosewho sell sexmay
do it to fund a drug habit, or they may have been involved in
sex work first before turning to drug use [23]. In Bangladesh,
around 75% of IDUs reported having unprotected sex in
their last sexual encounter with a commercial sex worker
[15]. Previous reports from Bangladesh showed that female
IDUs are particularly vulnerable, as most of them reported
selling sex to support their addiction and depended on their
male partners to buy their drugs and shared needles with
them [24]. Another study in Bangladesh reported that among
female IDUs 61% reported selling sex [6]. In our study, of
the 11 female participants, none reported any self-income or
occupation as sex worker.
HIV can spread extremely rapidly among IDUs sharing
needles, and IDUs provide a “bridge” for HIV transmission
to their sexual partners and children. One approach has
been to attempt to reduce drug use by strengthening drug
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interdiction and enforcement policies [25]. However, such
policies are not necessarily effective in controlling the drug
supply; they may simply reroute drug trade elsewhere, and
they may indirectly result in raising risky behavior that
spreads HIV.
The Narcotics Control Act (1990) of Bangladesh made
drug use a criminal offense and drug users criminals and
called for mandatory treatment of drug users. The act gave
law enforcement agents control over drug sales and use and
provision for harassment of drug sellers and users. How-
ever, the National AIDS Policy and the National HIV/AIDS
Strategic Plan incorporated harm reduction services for IDUs
in its strategic plan and law reform remains an urgent
need in order to facilitate intervention activities with drug
users.
There is a need to understand the barriers as well as
the facilitators for NEPs among IDUs in order to improve
health seeking behavior and awareness. Our data showed that
a great majority of the participants did not know where to
seek treatment, considered treatment too expensive, andwere
willing to use NEPs. Thus, efforts to promote NEPs through
government funded programs and creating awareness among
the IDUs in Bangladesh are needed. The keys to reducing the
rapid spread of HIV/AIDS among IDUs are, first, recognition
of injecting drug use as a potential problem and, second,
early intervention that includes harm reduction and drug
treatment [26, 27]. Evidence shows that IDUs do change
their risky injecting behavior as a result of harm reduction
programs and sometimes without large-scale intervention
efforts [2, 27]. The two important components for harm
reduction programs are education and provision of themeans
with which to change behavior. The latter may include sterile
needles (through either NEPs or availability in pharmacies
without a prescription), bleach, and/or drug rehabilitation
programs. Interventions to prevent sexual transmission from
IDUs to their partners through increased condom use have
met with only limited success but are vital for preventing the
spread of HIV out of the injecting group and into the general
population [28].
The WHO defined a comprehensive package of nine
interventions for IDUs, of which the following four have
evidence for effectiveness in reducing HIV incidence: needle
and syringe programs (NSP), medication-assisted therapy
(MAT), antiretroviral therapy (ART), and HIV counseling
and testing (HCT) [2]. At least 60% coverage is likely to
be required to reduce HIV incidence. Evidence from LMIC
contexts suggests that NSP and MAT can reduce high-risk
injecting behavior, HCT can reduce risky sexual behavior,
and ART can plausibly have preventive benefit among IDUs
for onward parenteral transmission with clearer evidence
that antiretroviral therapy (ARV) can prevent onward sexual
transmission. Modeling analysis suggests that, compared
with current low coverage, a scale-up of these four interven-
tions in combination would be a beneficial and cost-effective
approach [2].
Despite several risk factors, the HIV/AIDS prevalence in
Bangladesh remains considerably low, which might be due to
the early interventions by the government and several NGOs,
targeted atmost at risk populations. Previous studies inNepal
and Indonesia have reported that HIV prevalence among
IDUs remained low for several years but then increased to
over 45% [2]. These studies also highlight the importance
of early interventions in the epidemic. However, currently
the coverage of interventions for IDUs is inadequate in
Bangladesh [29]. While the response to date has reduced
the level of HIV transmission and ensured many people
living with HIV (PLHIV) were under NEP coverage and
received treatment [30], sufficient justification exists on
human rights and public-health grounds for scaling up
evidence-based prevention of HIV infection among IDUs.
Social and structural changes for a combination intervention
approach for HIV/AIDS prevention are essential. Bangladesh
still has a rare window of opportunity to prevent significant
HIV epidemic by providing prevention service to those at
most risk of HIV infection including IDUs.
4.1. Limitations of the Study. Our study had several lim-
itations. First, the study participants were recruited from
a single drug addiction treatment site in Dhaka city. This
group is likely to have better health seeking behaviors than
those who do not seek treatment in a rehabilitation center.
Therefore, the results may not generalize to other IDUs in
Bangladesh. Second, the study participants were selected
purposively. Therefore, chances of selection bias could not
be ruled out. Third, our sample size was limited to 120
participants with a small number of female IDUs to compare
the gender differences. Finally, due to limited resources we
were not able to conduct statistical tests to determine the
predictors of injecting drug use and health seeking behavior.
Further studies with qualitative methods and evaluation of
combined interventions and cost-effectiveness of the inter-
ventions are recommended to identify the best solution for
Bangladesh.
5. Conclusion
Results of our study show that IDUs in Bangladesh have
several risky behavior practices and are at high risk of devel-
opingHIV. Awareness building, education, and interventions
specifically aimed at IDUs are needed, because programs
targeted at the general population may not reach IDUs or
influence their behavior. Scaling up and strengthening the
use of condoms and NEPs might help to reduce harm in this
vulnerable population group in Bangladesh and similar other
developing countries.
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